Roche and Exiqon to Co-Market Products for qPCR-based MicroRNA Profiling
July 22, 2010
Roche and Exiqon to Co-Market Products for qPCR-based MicroRNA Profiling
The co-marketing pact builds on a licensing agreement related to the same technologies that has been in place since at least 2005 and provides an entry point for Roche in the burgeoning miRNA field.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Exiqon's qPCR Assays, MicroRNA Arrays Drive Q1 Sales Up 33 Percent
May 24, 2011 / BioArray News - Exiqon Presents Data Supporting Use of PCR-Based miRNA Assay as Blood-Based Colon Cancer Dx
September 30, 2010 / PCR Insider - Exiqon Licenses LNA Tech to BD for Use in PCR-Based Infectious Disease Dxs
June 24, 2010 / PCR Insider - Korean Group Develops Inexpensive Sequence-Enrichment Method for Mutation Detection
November 3, 2011 / PCR Insider - Danish Study Backs Sensitivity of Exiqon qPCR Panels for Detecting miRNAs in Blood
September 1, 2011 / PCR Insider